Evidence map›Paper›PMID 28381266›Full record

Trial reportBMC nephrology2017

Cost-effectiveness of home telemonitoring in chronic kidney disease patients at different stages by a pragmatic randomized controlled trial (eNephro): rationale and study design.

Nathalie Thilly, Jacques Chanliau, Luc Frimat, Christian Combe, Pierre Merville, Philippe Chauveau, Pierre Bataille, Raymond Azar, David Laplaud, Christian Noël and 1 more

Registry-linked trialOpen access · goldAbstract readPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in BMC nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02082093 (Medico-economic Evaluation of a Telemedicine System for the Management of Chronic Renal Failure), which is not on this map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02082093 nacompletednot on this map

Medico-economic Evaluation of a Telemedicine System for the Management of Chronic Renal Failure

TypeinterventionalSponsorPharmagest InteractiveRan2015 to 2019Enrolled635ConditionsChronic Kidney DiseasesArmsTelemedicine System
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. eHealth interventions for people with chronic kidney disease.The Cochrane database of systematic reviews · 2019
    Pooled it
  3. Review
  4. KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2022
    Article
  5. Article
  6. European nephrologists' views on remote patient management for end-stage kidney disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Nathalie ThillyCHRU de Nancy, Plateforme d'Aide à la Recherche Clinique, Nancy, France. n.thilly@chru-nancy.fr.
Jacques ChanliauAssociation Lorraine pour le Traitement de l'Insuffisance Rénale (ALTIR), Nancy, France.
Luc FrimatEA 4360 APEMAC, Université de Lorraine, 54511, Vandoeuvre-lès-Nancy Cedex, Nancy, France.
Christian CombeCHU de Bordeaux, Service de Néphrologie Transplantation Dialyse, Bordeaux, France.
Pierre MervilleCHU de Bordeaux, Service de Néphrologie Transplantation Dialyse, Bordeaux, France.
Philippe ChauveauCHU de Bordeaux, Service de Néphrologie Transplantation Dialyse, Bordeaux, France.
Pierre BatailleCH de Boulogne sur Mer, Service de Néphrologie, Boulogne sur Mer, France.
Raymond AzarCH de Dunkerque, Service de Néphrologie, Dunkerque, France.
David LaplaudSociété Pharmagest, Nancy, France.
Christian NoëlCHU de Lille, Service de Néphrologie, Lille, France.
Michèle KesslerCHRU de Nancy, Service de Néphrologie, Nancy, France.
Centre Hospitalier Régional et Universitaire de Nancy · FRUniversité de Bordeaux · FRAGIR à dom · FRCentre d’Investigation Clinique Innovation Technologique de Nancy · FRCentre Hospitalier Universitaire de Lille · FRCentre National de la Recherche Scientifique · FRUniversité d'été de Boulogne-sur-Mer · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHome telemonitoring has developed considerably over recent years in chronic diseases in order to improve communication between healthcare professionals and patients and to promote early detection of deteriorating health status. In the nephrology setting, home telemonitoring has been evaluated in home dialysis patients but data are scarce concerning chronic kidney disease (CKD) patients before and after renal replacement therapy. The eNephro study is designed to assess the cost effectiveness, clinical/biological impact, and patient perception of a home telemonitoring for CKD patients. Our purpose is to present the rationale, design and organisational aspects of this study.

methodseNephro is a pragmatic randomised controlled trial, comparing home telemonitoring versus usual care in three populations of CKD patients: stage 3B/4 (n = 320); stage 5D CKD on dialysis (n = 260); stage 5 T CKD treated with transplantation (n= 260). Five hospitals and three not-for-profit providers managing self-care dialysis situated in three administrative regions in France are participating. The trial began in December 2015, with a scheduled 12-month inclusion period and 12 months follow-up. Outcomes include clinical and biological data (e.g. blood pressure, haemoglobin) collected from patient records, perceived health status (e.g. health related quality of life) collected from self-administered questionnaires, and health expenditure data retrieved from the French health insurance database (SNIIRAM) using a probabilistic matching procedure. DISCUSSION: The hypothesis is that home telemonitoring enables better control of clinical and biological parameters as well as improved perceived health status. This better control should limit emergency consultations and hospitalisations leading to decreased healthcare expenditure, compensating for the financial investment due to the telemedicine system.

trial registrationThis study has been registered at ClinicalTrials.gov under NCT02082093 (date of registration: February 14, 2014).

Indexed as

General PracticeNephrologyBlood Pressure DeterminationBody WeightClinical Laboratory ServicesCommunicationCost-Benefit AnalysisDelivery of Health CareDisease ManagementElectronic Health RecordsFranceHumansInternetKidney Failure, ChronicKidney TransplantationPhysician-Patient RelationsChronic kidney diseaseCost-effectiveness evaluationDialysisHome telemonitoringKidney transplantationTelemedicine

Identifiers

PMID28381266
PMCPMC5381043
OpenAlexW2604331092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.